UnitedHealth Group spent about $872 million during the first quarter responding to the cyberattack at its Change Healthcare division and expects that full-year costs could reach $1.6 billion.
Apr 16, 2024
0
0
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.
May 3, 2022
0
10
Moderna said Thursday it took in $1.1 billion in deposits in the third quarter for a coronavirus vaccine that it is "actively preparing" to launch.
Oct 29, 2020
0
1
